Regulus Therapeutics Ownership | Who Owns Regulus Therapeutics?

Overview Forecast RevenueFinancials Chart

Regulus Therapeutics Ownership Summary

Regulus Therapeutics is owned by 80.99% institutional investors, 2.69% insiders, and 16.32% retail investors. Blackrock is the largest institutional shareholder, holding 13.81% of RGLS shares. Federated Hermes Kaufmann R is the top mutual fund, with 11.60% of its assets in Regulus Therapeutics shares.

RGLS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Regulus Therapeutics	80.99%	2.69%	16.32%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	3.97M	13.81%	$7.08M
Cvi	401.01K	0.62%	$715.81K
Goldman sachs group	212.38K	0.32%	$335.56K
Nuveen asset management	85.60K	0.13%	$135.25K
Bank of america corp /de/	33.06K	0.12%	$59.01K
Morgan stanley	62.97K	0.10%	$112.40K
Peak6 investments	60.00K	0.09%	$107.10K
Wolverine trading	24.50K	0.09%	$43.73K
Susquehanna group, llp	36.19K	0.06%	$57.18K
Alliancebernstein	26.88K	0.04%	$42.47K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cvi	401.01K	0.62%	$715.81K
Peak6 investments	60.00K	0.00%	$107.10K
Blackrock	3.97M	0.00%	$7.08M
Goldman sachs group	212.38K	0.00%	$335.56K
Geode capital management	-	-	-
Parallel advisors	-	-	-
Proshare advisors	-	-	-
Prelude capital management	-	-	-
Renaissance	-	-	-
Legal & general group	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	3.97M	0.00%	3.90M
Peak6 investments	60.00K	0.00%	60.00K
Susquehanna group, llp	36.19K	-	36.19K
Morgan stanley	62.97K	-	35.15K
Goldman sachs group	212.38K	0.00%	33.37K

Top Sellers

Holder	Shares	% Assets	Change
Federated hermes	-	-	-15.82M
Nea management company	-	-	-6.47M
Octagon capital advisors lp	-	-	-4.64M
Blackrock funding, inc. /de	-	-	-4.17M
Vanguard group	-	-	-3.95M

New Positions

Holder	Shares	% Assets	Change	Value
Peak6 investments	60.00K	0.00%	60.00K	$107.10K
Susquehanna group, llp	36.19K	-	36.19K	$57.18K
Bnp paribas arbitrage, snc	7.15K	-	7.15K	$11.30K

Sold Out

Holder	Change
Parallel advisors	-10.00
Eversource wealth advisors	-46.00
True wealth design	-60.00
Continuum advisory	-300.00
Russell investments group	-458.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	79	12.86%	53,596,805	0.16%	80	1.21%	32	-	28	64.71%
Dec 31, 2024	69	-6.76%	53,508,278	-5.68%	81	1.09%	32	-11.11%	17	13.33%
Sep 30, 2024	74	13.85%	56,730,064	3.44%	86	1.20%	36	-10.00%	15	-6.25%
Jun 30, 2024	65	38.30%	54,841,329	20.21%	85	1.70%	40	11.11%	16	300.00%
Mar 31, 2024	47	88.00%	45,620,979	398.54%	70	35.12%	36	260.00%	4	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Federated Hermes Kaufmann R	8.02M	11.60%	143.40K
Federated Hermes Kaufmann Small Cap A	7.52M	10.87%	102.50K
Federated Hermes Kaufmann Small Cap Grow	3.07M	4.43%	102.50K
Federated Hermes Kaufmann Growth	2.82M	4.08%	143.40K
Vanguard US Total Market Shares ETF	2.50M	3.78%	-
Vanguard Total Stock Mkt Idx Inv	2.50M	3.61%	-
T. Rowe Price Health Sciences	1.68M	2.57%	1.68M
Victory Science & Technology	1.52M	2.30%	-11.22K
iShares Russell 2000 ETF	1.59M	2.30%	-
Vanguard Institutional Extnd Mkt Idx Tr	946.40K	1.37%	6.02K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 03, 2025	Klassen Preston	President & Head of R & D	Buy	$95.85K
Jan 30, 2025	Hagan Joseph P	Chief Executive Officer	Buy	$54.26K
Jan 30, 2025	BALTIMORE DAVID	-	Buy	$20.79K
Jan 13, 2025	Aker Christopher Ray	Sr. VP & General Counsel	Sell	$48.69K
Jan 14, 2025	Aker Christopher Ray	Sr. VP & General Counsel	Sell	$6.43K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	1	-
2025 Q1	2	7
2024 Q3	1	-
2024 Q2	-	-
2024 Q1	-	3

RGLS Ownership FAQ

Who Owns Regulus Therapeutics?

Regulus Therapeutics shareholders are primarily institutional investors at 80.99%, followed by 2.69% insiders and 16.32% retail investors. The average institutional ownership in Regulus Therapeutics's industry, Biotech Stocks , is 304.14%, which Regulus Therapeutics falls below.

Who owns the most shares of Regulus Therapeutics?

Regulus Therapeutics’s largest shareholders are Blackrock (3.97M shares, 13.81%), Cvi (401.01K shares, 0.62%), and Goldman sachs group (212.38K shares, 0.32%). Together, they hold 14.75% of Regulus Therapeutics’s total shares outstanding.

Does Blackrock own Regulus Therapeutics?

Yes, BlackRock owns 13.81% of Regulus Therapeutics, totaling 3.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.08M$. In the last quarter, BlackRock increased its holdings by 3.9M shares, a 5733.89% change.

Who is Regulus Therapeutics’s biggest shareholder by percentage of total assets invested?

Cvi is Regulus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.62% of its assets in 401.01K Regulus Therapeutics shares, valued at 715.81K$.

Who is the top mutual fund holder of Regulus Therapeutics shares?

Federated Hermes Kaufmann R is the top mutual fund holder of Regulus Therapeutics shares, with 11.60% of its total shares outstanding invested in 8.02M Regulus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools